Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Baxter is sending an important product information notice to customers about the implementation of an additional warning in homechoice/homechoice pro device product labeling related to patients more vulnerable to unintended increased intraperitoneal volume (iipv). the warning identifies symptoms related to unintended iipv that may be seen in neonates infants small children and any patient with significant heart or lung disease and provides specific instructions for the patient to follow if iipv is suspected.